Study of differentiation and proliferation of normal and leukemic myeloid hematopoietic cells is my major research. In this arena the proposal focuses on three areas: 1) control of expression of myelopecoxidase (MPO): 2) effects of tumor necrosis factor (TNF) on normal and leukemic hematopoiesis: 3) role of p53 in normal and abnormal hematopoiesis. 1) MPO is an enzyme important in killing microorganisms and is expressed abundantly at only one stage of myeloid differentiation Using a variety of myeloid leukemic cell lines, we shall: A.) examine chromatin structure, methylation pattern, and association with the nuclear matrices of the MPO gene region during myeloid differentiation and correlate the results with MPO expression; B.) identify by CAT and electrophoretic mobility shift assays those DNA sequences that regulate MPO expression; C.) purify and study the biological activities of proteins regulating MPO expression; D.) utilize recombinant MPO/oncogenes in transgenic mice to define the activity of 5' sequences of MPO in different tissues; E.) define the cause of MPO deficiency in patients with hereditary MPO deficiency and in those with myeloid leukemia. 2.) TNF is a monokine which we recently discovered can cause production of granulocyte (G-) and granulocyte-macrophage (GM-) colony stimulating factor (CSF) is mesenchymal cells. This may constitute a major mechanism to control production of granulocytes and macrophages. We will: A) characterize at the cellular and molecular level how TNF stimulates mesenchymal cells to synthesize CSF; B) define the effects of TNF on normal and leukemic hematopoiesis in vivo using both mouse and man. 3.) p53 is nuclear protein associated with cell division and capable of causing cell transformation. We found that p53 is phosphorylated in transformed T-lymphocytes but not in their normal countpart. We shall determine the site of p53 phosphorylation and attempt to characterize its importance. Also, we will define the role of p53 in mediating transcription. In another arena, we discovered that p53 is frequently rearranged in human osteosarcomas; this finding may help explain how osteosarcomas develop. Using human osteosarcomas we shall: A.) Determine the frequency of p53 rearrangement; B.) Define the structure of the p53 rearrangement and look for alterations in gene expression as a consequence of this rearrangement; C.) Develop an in vivo murine model of osteosarcoma to study the rearranged p53.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA026038-09
Application #
3167152
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1979-07-01
Project End
1992-12-31
Budget Start
1988-01-01
Budget End
1988-12-31
Support Year
9
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Sun, Q-Y; Ding, L-W; Tan, K-T et al. (2017) Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD). Leukemia 31:1-10
Ding, L-W; Ikezoe, T; Tan, K-T et al. (2017) Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency. Leukemia 31:244-245
Ding, Ling-Wen; Sun, Qiao-Yang; Tan, Kar-Tong et al. (2017) Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia. Cancer Res 77:390-400
Madan, V; Shyamsunder, P; Han, L et al. (2016) Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia 30:1672-81
Cao, Q; Gearhart, M D; Gery, S et al. (2016) BCOR regulates myeloid cell proliferation and differentiation. Leukemia 30:1155-65
Sun, Haibo; Lin, De-Chen; Guo, Xiao et al. (2016) Inhibition of IRE1?-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia. Oncotarget 7:18736-49
Nowak, Daniel; Liem, Natalia L M; Mossner, Maximilian et al. (2015) Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance. Exp Hematol 43:32-43.e1-35
Madan, Vikas; Kanojia, Deepika; Li, Jia et al. (2015) Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome. Nat Commun 6:6042
Garg, Manoj; Okamoto, Ryoko; Nagata, Yasunobu et al. (2015) Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraft. J Clin Endocrinol Metab 100:725-35
Garg, Manoj; Nagata, Yasunobu; Kanojia, Deepika et al. (2015) Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse. Blood 126:2491-501

Showing the most recent 10 out of 226 publications